Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Determinants of early-onset cachexia in transgenic mouse model of pancreatic cancer

ABSTRACT: Since the lack of understanding of signaling mechanisms in cancer cachexia progress, the exact time point of cachexia onset remains unpredictable. To determine the molecular phenotypes of single cells at the utmost approximated timepoint of cachexia onset, we hypothesized that the tumor microenvironment and circulating blood cells could serve as biomarkers of cachexia-onset to map out the determinants of muscle wasting in a mouse model of cancer cachexia. Depending on individual tumors, subcutaneous syngeneic implantation of xenografts derived from the transgenic KrasG12D/+;Trp53flox/flox;Pdx1-Cre mouse model of pancreatic cancer-induced early-onset cachexia (EOCX) and Pre-cachexia (PreCX) in individual recipient mice. To characterize the dominants of cachexia-onset, immediate fresh collection of samples and processing for single-cell RNA sequencing, allowed the analysis of gene expression in the subcutaneous xenografted tumors and the peripheral blood mononuclear cells (PBMC) at the single-cell level. Our dataset classified high-quality cells-- 29,885 PBMCs and 24,925 subcutaneous tumor cells into subtypes. By dissecting the differentially expressed markers genes of EOCX versus the PreCX, these markers may represent the determinants of cachexia in multiple cell types in circulating PBMCs and in tumors at the single-cell resolution.

ORGANISM(S): Mus musculus

PROVIDER: GSE214497 | GEO | 2025/08/13

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Effect of disruption of IL-6 in cachectic C26 tumor on gene expression

Project description:The IL-6 was reported as a key cachectic factor in mice inoculated with colon carcinoma 26 (C26) cells, a widely used cancer cachexia model. However, we identified We found that the growth of IL-6 KO tumors was dramatically delayed. More strikingly, while IL-6 KO tumors eventually reached the similar size as wild-type tumors, cachexia still took place, despite no elevation in circulating IL-6. We further showed that IL-6 promotes tumor growth by facilitating immune evatioon but is dispensable for cachexia.

2024-04-10 | GSE253861 | GEO

Determinants of early-onset cachexia in transgenic mouse model of pancreatic cancer

Project description:Determinants of early-onset cachexia in transgenic mouse model of pancreatic cancer

| PRJNA885622 | ENA

Formation of colorectal liver metastases induces musculoskeletal and metabolic abnormalities

Project description:Advanced colorectal cancer (CRC), a leading cause of death worldwide, is often accompanied by the development of liver metastases (LM), as well as skeletal muscle (SkM) wasting, i.e. cachexia. Despite affecting the majority of CRC patients, cachexia remains understudied and uncured. Moreover, only a single model of LM associated with CRC has been developed for the study of cachexia. Here we examined differential gene expression of skeletal muscles deriving from subcutaneous and metastatic C26 tumor hosts. Tumor hosts displaying LM experienced exacerbated muscle wasting compared to tumor hosts without LM.

2020-04-18 | GSE142455 | GEO

ADIPOSE TISSUE PATHWAYS INVOLVED IN WEIGHT LOSS OF CANCER CACHEXIA

Project description:The regulatory gene pathways underlying the loss of adipose tissue in cancer cachexia are unknown and were explored using pangenomic transcriptome profiling. Gene expression profiles (Human Gene 1.0 ST) of abdominal subcutaneous adipose tissue were studied in gastrointestinal cancer patients with (N=13) or without (N=14) cachexia. Data analyses were performed using the Affymetrix GeneChip Operating Software (GCOS) Version 1.4.

2010-04-10 | E-GEOD-20571 | biostudies-arrayexpress

Transcriptomic analysis of flies with Yki gut tumors

Project description:Purpose: Flies with Yki gut tumors is a widely used Drosophila model of cancer cachexia. Since cancer cachexia is a multi-organ syndrome, its investigation requires understanding how tumors induce metabolic dysfunction in peripheral organs. To address this, we performed a body-wide single-cell transcriptome analysis of Yki tumor model flies. Methods: snRNA-seq analysis of whole-body flies (without heads) with and without Yki gut tumors. Results: The data provides information of transcriptome alternations related to tumor-induced cachexia, including expression of metabolic genes and tumor-host organ communications. Conclusions: Cachexia phenotypes in Yki tumor model flies originated from metabolic dysregulation in peripheral organs that induced by tumor secreted factors.

2025-02-21 | GSE229526 | GEO

Expression data from murine adipose tissue endothelial cells during pre-cachexia

Project description:Endothelial cells form a barrier between the contents of the blood and adipocytes. We hypothesized that during cancer cachexia development, transcriptomic changes alter angiocrine signals to contribute to adipose tissue remodelling. We used microarrays to observe changes in gene expression in endothelial cells isolated from subcutaneous fat of mice during pre-cachexia.

2023-06-19 | GSE212562 | GEO

Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer

Project description:Pancreatic cancer is characterized by a high frequency of cachexia, pain and neural invasion (N-inv). Neural damage is occurred by N-inv and modulates pain and muscle atrophy via the activation of astrocyte in the connected spine. The activated astrocyte by N-inv, thus, may affect cachexia in pancreatic cancer. Clinical studies in patients and autopsy cases with pancreatic cancer have revealed that N-inv is related to cachexia and astrocytic activation. We established a novel murine model of cancer cachexia using N-inv of human pancreatic cancer cells. Mice with N-inv showed a loss of body weight, skeletal muscle, and fat mass without appetite loss, which are compatible with an animal model of cancer cachexia. Activation of astrocytes in the spinal cord connected with N-inv was observed in our model. Experimental cachexia was suppressed by disrupting neural routes or inhibiting the activation of astrocytes. These data provide the first evidence that N-inv induces cachexia via astrocytic activation of neural route in pancreatic cancer. We produced neural invasion (N-inv) model using intraneural injection of Capan-1 cells to left sciatic nerve of male SCID mouse. For controls, subcutaneous model (SC) and PBS model were produced. Microarray analysis was performed using the first lumbar cord (L1) from PBS, SC, and N-inv mice at 6 w (n = 2 each).

2011-12-07 | E-GEOD-34189 | biostudies-arrayexpress

Genome-wide analysis of skeletal muscle gene expression in mice with C26 tumor-induced muscle wasting and cachexia

Project description:Analysis of gene expression in CD2F1 mice with cancer cachexia due to implantation of C26 colon carcinoma cells. Total RNA obtained from quadriceps muscle of female CD2F1 mice with early weight loss (10%) or severe weight loss (15%) due to intrascapular subcutaneous implantation of one million C26 colon adenocarcinoma cells.

2011-08-29 | E-GEOD-24112 | biostudies-arrayexpress

Sex-specific Phenotypes modulated by activin in pancreatic cancer cachexia and mortality

Project description:Cachexia frequently develops in patients with pancreatic ductal adenocarcinoma (PDAC) and contributes to cancer deaths.Sex differences have been observed in cancer cachexia; however, the underlying molecular mechanisms are far less addressed. We assessed sex difference in PDAC cachexia phenotypes in the KPC (Kras-G12D;Trp-R172H;Pdx1::Cre) genetically engineered mouse model of PDAC and profiled gene expression in the quadriceps skeletal muscles. Males with PDAC experienced earlier cachexia-onset than the female counterpart and activin blockade by ACVR2B/Fc reduced cachexia sympotomes in males but not females. PDAC induced earlier global transcritome alterations in males than females.

2022-05-10 | GSE157251 | GEO

Molecular mechanisms of Target organ damage in youth with primary hypertension [bulk RNA-Seq 3]

Project description:High blood pressure or Primary Hypertension is associated with target organ damage (TOD) in both adults and youth, where TOD predicts the adverse cardiovscular (CV) events. The mechanisms involved in blood pressure mediated TOD are limitedly understood in onset of TOD. To understand this, first using RNA sequencing, we identified candidate differentially expressed genes in circulating PBMCs of study participants with and without hypertension and elevated left ventrivlar mass index . Next, through miRNA and whole genome bisulphite sequencing of circulating PBMCs we determined the epigenetic regulators of TOD. Also, using LCMS, serum proteomics, the key circulatory protein involved in advancing CV- TOD events was identified. In conclusion, multiomics approach was utilized to define the circulatory regulators involved in BP mediated CV-TOD.

2024-07-31 | GSE262815 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data